These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405 [TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences. Wang S; An R; Han X; Zhu K; Xue Y Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237 [TBL] [Abstract][Full Text] [Related]
5. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease. Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977 [TBL] [Abstract][Full Text] [Related]
8. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease. Dobson LS; Lorigan PC; Coleman RE; Hancock BW Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722 [TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia]. Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513 [TBL] [Abstract][Full Text] [Related]
18. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen. Surwit EA; Childers JM J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900 [TBL] [Abstract][Full Text] [Related]
19. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience. Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348 [TBL] [Abstract][Full Text] [Related]
20. Development of single-agent chemotherapy regimens for gestational trophoblastic disease. Homesley HD J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]